On Nov. 12, 2021, with COVID-19 infections surging worldwide, a united group of 18 companies representing a large…
On Nov. 10, 2021, Meridian Bioscience announced that their Revogeneﾮ SARS-CoV-2 assay was granted Emergency Use Authorization by…
On Nov. 9, 2021, Moderna announced that it has submitted for a variation to the conditional marketing authorization…
On Nov. 8, 2021, Cocrystal Pharma announced that its SARS-CoV-2 main protease inhibitors showed potent in vitro pan-viral…
On Nov. 5, 2021, Chugai Pharmaceutical, announced that it had obtained approval from the Ministry of Health, Labour…
On Nov. 5, 2021, the USDA’s (USDA) National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 in two spotted…
On Nov. 5, 2021, scientists at the National Institutes of Health announced they had found that a process…
On Nov. 5, 2021, Pfizer announced it was investigational novel COVID-19 oral antiviral candidate, PAXLOVID, significantly reduced hospitalization…
On Nov. 3, 2021, the World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXIN (developed…
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
On Nov. 2, 2021, OraSure Technologies announced that the EUA for its InteliSwab™ COVID-19 rapid tests has been…
On Nov. 2, 2021, the National Institutes of Health (NIH) announced support for a four-year follow-up study on…
On Nov. 1, 2021, for the first time in the U.S., the transmission of COVID-19 from pet parent…
On Nov. 1, 2021, Novavax announced the completion of its rolling submission to Health Canada for authorization of…
On Nov. 1, 2021, Novavax and Serum Institute of India announced that the National Agency of Drug and…
Our Life-Saving Vaccines cartoon illustrates four invaluable vaccines that have affected human civilization throughout history from smallpox and…
On Oct. 29, 2021, the Centers for Disease Control and Prevention (CDC) published “new science” reinforcing that vaccination…
On Oct. 29, 2021, Novavax announced the completion of its rolling submission to the Therapeutic Goods Administration (TGA)…
On Oct. 29, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had authorized…
On Oct. 27, 2021, Hologic announced the commercial availability of its Aptima SARS-CoV-2/Flu test in North America and…
On Oct. 27, 2021, the Medicines Patent Pool (MPP) and Merck announced a voluntary licensing agreement to facilitate…
On Oct. 27, 2021, Fulgent Genetics announced that it has launched an antibody test for COVID-19 which will…
On Oct. 27, 2021, researchers published interim results in The New England Journal of Medicine from a Phase…
On Oct. 26, 2021, Moderna announced a new Memorandum of Understanding (MoU) to make up to 110 million…
On Oct. 26, 2021, Moderna announced that Swissmedic had authorized a booster dose of Spikevax, the Company’s vaccine…
On Oct. 26, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration’s (FDA) Vaccines and…
On Oct. 25, 2021, researchers from across the UK, led by the University of Oxford, have reported on…
On Oct. 25, 2021, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
On Oct. 22, 2021, the U.S. Department of Veterans Affairs (VA) announced that it had begun offering Moderna…
On Oct. 21, 2021, the National Institutes of Health (NIH) announced that a booster dose of the mRNA-1273…